MeSH tree: A15.145.229.637.555.567.569.200.700
Researchers at Columbia University have identified a previously unknown population of fibroblasts that may protect lung tumors from immune attack. The work, published in Nature Immunology, illuminates a previously unknown ...
Aug 24, 2026
1
59
Immunotherapy has transformed outcomes for many cancer patients. Unlike conventional treatments, these therapies do not attack tumors directly. Instead, they enable the body's immune system to identify and kill cancer cells ...
Aug 20, 2026
0
7
Obesity can weaken the immune system's tumor-killing responses in lung cancer, leading to disease progression, but a new study by experts at Roswell Park Comprehensive Cancer Center reveals that exercise may reverse this ...
Aug 17, 2026
0
18
Coronary artery disease, which is caused by plaque buildup in the arteries that supply blood to the heart, can appear stable for long periods without causing any symptoms. But the disease can become unstable at any time and ...
Aug 12, 2026
0
13
A new study led by researchers at The University of Texas MD Anderson Cancer Center has shown that inflammatory arthritis occurring as a side effect of immune checkpoint inhibitors behaves like an immune-memory disease, suggesting ...
Aug 12, 2026
0
82
The tissue microenvironments surrounding HIV-infected immune cells look a lot like those surrounding cancerous tumors, reports a new Northwestern University study.
Aug 5, 2026
0
7
Researchers from the University of Minnesota Medical School have identified why pancreatic cancer is difficult for the immune system to recognize and attack, paving the way for a new approach to improve immunotherapy. The ...
Jul 21, 2026
0
14
A research team led by experts at Roswell Park Comprehensive Cancer Center has documented new evidence that excess abdominal fat increases the risk of developing non-small cell lung cancer. Published in the Journal of Thoracic ...
Jul 8, 2026
0
7
"Peacemaker" immune cells could help treat diseases ranging from type 1 diabetes to neurodegeneration by restoring immune tolerance, according to a new paper in Frontiers in Science.
Jun 25, 2026
0
10
Dual-target CAR T-cell therapy for recurrent glioblastoma (GBM), delivered directly into the cerebrospinal fluid (CSF), triggers a broad immune response, with natural killer (NK) cell activation linked to better patient outcomes ...
Jun 15, 2026
0
3
